News

CalciMedica's Groundbreaking Presentations at Medical Conferences

CalciMedica's Groundbreaking Presentations at Medical Conferences

CalciMedica's Acceptance of Abstracts for Important Presentations

CalciMedica Inc. (NASDAQ: CALC) is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies targeting calcium release-activated calcium (CRAC) channels. It is focused on therapies that address acute and chronic inflammatory and immunologic diseases. Recently, the company announced significant achievements regarding upcoming presentations at notable medical meetings.

Poster Presentation at Digestive Disease Week

CalciMedica's abstract has been accepted for a poster presentation at the esteemed Digestive Disease Week (DDW) 2025. This event will take place from May 3 to May 6, bringing together professionals in the digestive disease community.

Details of the Poster Presentation

The poster presentation will focus on critical findings related to patients diagnosed with Acute Pancreatitis (AP) and the accompanying Systemic Inflammatory Response Syndrome (SIRS). The study presents evidence indicating these patients show a larger volume of distribution compared to healthy volunteers, which is promising for future treatment approaches.

Who Will Present?

This vital presentation will be delivered by Kenneth A. Stauderman, Ph.D., who serves as CalciMedica's co-Founder and Chief Scientific Officer. His expertise will contribute significantly to the discussion of clinical acute pancreatitis management during this session.

Oral Presentation at ASN Conference

Additionally, Sudarshan Hebbar, M.D., the Chief Medical Officer of CalciMedica, will present at the American Society of Nephrology (ASN) 3rd Acute Kidney Injury: From Bench to Bedside Conference.

Insights from Clinical Trials

Dr. Hebbar will share insights from his experiences with the design of AKI clinical trials. This presentation aims to shed light on the intricacies involved in effective trial methodologies and the progress regarding acute kidney injuries. It will take place on Tuesday, May 6, from 8:00 to 10:00 a.m. ET.

Panel Discussion on Non-Academic Careers

Furthermore, Dr. Hebbar will also participate in a panel discussion that addresses non-academic careers in science, emphasizing diversity and career paths that extend beyond traditional academia.

Details of the Panel Discussion

This engaging panel will occur on Wednesday, May 7, from 4:00 to 4:30 p.m. ET, and aims to enlighten attendees about various career trajectories and opportunities available in the scientific field.

About CalciMedica

CalciMedica is committed to advancing treatments for inflammatory and immunologic diseases. Their proprietary technology focuses on inhibiting CRAC channels, which plays a pivotal role in modulating immune responses. This innovative approach holds the potential to safeguard against tissue damage associated with life-threatening conditions that currently lack effective therapies.

The company's lead candidate, Auxora™, has shown positive outcomes in multiple clinical trials, demonstrating promise for patients suffering from serious medical conditions. Noteworthy trials include the Phase 2b trial (CARPO), specifically targeting acute pancreatitis and SIRS.

Clinical Trial Landscape

CalciMedica has recently concluded a Phase 2 trial (CARDEA), focusing on COVID pneumonia, and is actively engaged in further trials including KOURAGE and CRSPA. These trials aim to understand the effects of their treatments on various conditions, including acute kidney injury and pediatric patients with specific needs.

Contact and Further Information

For additional details on these presentations and ongoing initiatives, please visit CalciMedica's website to explore their medical events and studies. Their journey represents a commitment to excellence in medical research and patient care.

Frequently Asked Questions

What posts will CalciMedica present at the DDW event?

CalciMedica will present research on patients with Acute Pancreatitis and their larger volume of distribution compared to healthy volunteers.

Who will represent CalciMedica at the ASN conference?

Dr. Sudarshan Hebbar, the Chief Medical Officer, will deliver insights and participate in discussions.

When is the ASN conference presentation scheduled?

The oral presentation is scheduled for May 6 from 8:00 to 10:00 a.m. ET.

What topics will the panel discussion cover?

The panel discussion will focus on non-academic careers in science and diverse career pathways.

Where can I find more information about CalciMedica's clinical trials?

More information can be found on CalciMedica's investor relations webpage detailing their medical events and publications.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ALP's Bold NYC Pop-Up: A Gamble or Genius Move?

Updated Category News Views 20

ALP Swings Big in the Big Apple Here's a move that's about as loud as blaring your TV at midnight — ALP, the nicotine pouch brand that’s been taking quiet corners of rural America by storm, is barging into New York City with a brazen pop-up and a parade of marketing antics. Think of it as taking the Wild West and plunking it down in the urban jungle. They're...

Continue Reading
Bimbo Bakeries Teamsters Gear Up for Strike in NJ

Updated Category News Views 73

A Brewing Storm at Bimbo Bakeries The morning air in East Brunswick fills with more than just the scent of fresh bread; there’s a tension you can slice through with a butter knife. Unwavering and fired-up, over 90 workers at Bimbo Bakeries have thrown their hats into the ring, ready to strike to protect something as sacred as the dough they churn—Teamsters' health...

Continue Reading
Skyways Unleashes Skyreach: A Bold Step in Autonomous Cargo

Updated Category News Views 43

Dropping Cargo the New Way No more messing around with runways and cumbersome logistics—Skyways just took a sledgehammer to traditional cargo transport with the launch of its Skyreach platform. This bad boy is a long-range autonomous Vertical Takeoff and Landing (VTOL) aircraft that promises to shake up the defense and commercial sectors. We've got flights kicking off...

Continue Reading
PNU and Cellenkos Team Up for Biotech Advancements

Updated Category News Views 121

Paving New Paths in Biotech Collaboration When a university and a biotech company shake hands to bolster their capabilities in the ever-evolving field of clinical trials and cell and gene therapies, investors and industry buffs alike should perk up. The College of Medicine at Princess Nourah bint Abdulrahman University (PNU) has just inked a Memorandum of Understanding...

Continue Reading
Solidion Technology's Q3 Results: Strong Cash, EPS Growth

Updated Category News Views 20

Solidion Makes Big Waves with Q3 Financial Performance Hot off the press, Solidion Technology, Inc. (NASDAQ: STI) has released its third quarter 2026 financial results, and let me tell you, it's a breath of fresh air for this advanced battery technology player. Maintaining a robust cash position and showcasing a stark contrast in earnings from last year, the company...

Continue Reading
WIN Expands Global Family Support to 124 Countries

Updated Category News Views 55

WIN's Ambitious Global Expansion In the ever-twisting labyrinth of corporate benefits, WIN is stepping up its game. We're talking an expansion that balloons past traditional fertility offerings into a global medley of support services covering every conceivable family and health scenario. It ain’t just about making babies anymore. When you're dealing with 124 countries,...

Continue Reading
O-I Glass Faces Legal Storm Over Misleading Investor Claims

Updated Category News Views 22

Turbulence Hits O-I Glass Stock Another day, another company in hot water—and today, it's O-I Glass, Inc. (NYSE: OI) we're talking about. The company's shares plummeted by 15.01% in one fell swoop on July 29, 2026, right after it dropped its financial bombshell. Let’s break this drama down, shall we? The Legal Brass Tacks Investors who took the bait on O-I Glass...

Continue Reading
Weinberger Law Group Secures Top Tier Family Law Ranking

Updated Category News Views 42

A Testament to Legal Mastery: Weinberger's Latest Accolade In the crowded field of family law, standing out takes more than legal chops. Services have to resonate deeply with the real-life messiness of people's lives. That's what makes Weinberger Divorce & Family Law Group's ranking on the 2027 Best Law Firms® list a real feather in their cap. They're holding down Tier 1...

Continue Reading
Spatial Genomics Market Set for Major Expansion by 2031

Updated Category News Views 86

The Rise of Spatial Genomics You’ve got to hand it to the science behind spatial genomics and transcriptomics—this arena’s not just on a hot streak; it’s scorching. We’re staring down the barrel of a market raring to more than double in value, surging from a worth of USD 0.67 billion in 2026 straight to the big USD 1.23 billion in 2031. The CAGR that’s...

Continue Reading
Strathcona Resources Q3 2026: Dividends, Deals, and Growth

Updated Category News Views 225

Digging into Strathcona's Third Quarter Strathcona Resources (TSX: SCR) is strutting its stuff again, dropping a third-quarter report that reads like a playbook for solid energy sector performance. First off, let’s talk about that dividend bump. The company decided to sprinkle some cheer with a 7% increase in its quarterly dividend, now at $0.32 per share. Not exactly...

Continue Reading

Top 5 Most Recently Viewed Articles

Quantexa Strengthens Advisory Board with Tech and Finance Experts

Updated Category News Views 237

Quantexa Expands Advisory Board with Industry Leaders Quantexa, a leader in Decision Intelligence (DI), has recently appointed two distinguished figures in technology and finance, enhancing its Advisory Board as part of its growth strategy. The company welcomes Steven Guggenheimer and Franck Petitgas to guide its ambition to broaden its global reach and innovate its...

Continue Reading
Key Insider Activity at Matador Resources Sparks Interest

Updated Category News Views 128

Key Insider Activity at Matador Resources Sparks Interest Recently, there was a notable insider purchase at Matador Resources Co (NASDAQ: MTDR) made by William Thomas Elsener, the Executive Vice President of the company. This transaction has stirred the interest of investors and analysts alike, particularly as it entails a purchase of 1,000 shares reported in a SEC...

Continue Reading
Hamilton ETFs Reveals Monthly Cash Distributions for 2025

Updated Category News Views 563

Hamilton ETFs Announces Monthly Cash Distributions Hamilton Capital Partners Inc. (“Hamilton ETFs”) is set to share its monthly cash distributions for the various ETFs listed on the Toronto Stock Exchange. These distributions pertain to the period concluding January 2025, offering investors a reliable income stream. Details of Monthly Distributions The anticipated...

Continue Reading
Effective Risk Management for Cryptocurrency Traders

Updated Category Crypto Views 318

For traders of cryptocurrencies, good risk management is knowing how volatile the market is, establishing reasonable objectives, and diversifying portfolios. Making educated choices is aided by using stop-loss and take-profit orders together with technical analysis tools. Success in trading over the long run depends on psychological risk management, risk management...

Continue Reading
Graitec's AI Vision: Transforming AECO with Three Horizons

Updated Category News Views 30

Graitec's Bold Move with AI in AECO You ever think you'd see the day where AI strides into architecture, engineering, construction, and operations (AECO) like it owns the place? That day is here, and Graitec is not just riding the wave—they're building the surfboard. It's not just about speeding things up; it's making sure there's accountability every step of the way....

Continue Reading